BCL-2 expression and prognosis of patients with endometrial carcinoma

International Journal of Cancer

Volumn 79, Issue 2, 1998, Pages 153-158

  Sakuragi, Noriaki ^a   Ohkouchi, Toshihiro ^a   Hareyama, Hitoshi ^a   Ikeda, Ken ^a   Watari, Hidemichi ^a   Fujimoto, Toshio ^a   Kuwabara, Michiya ^a   Yamamoto, Ritsu ^a   Sagawa, Tadashi ^a   Fujino, Takafumi ^a   Fujimoto, Seiichiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CYTOPLASM; ENDOMETRIUM CARCINOMA; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SOLID TUMOR; STATISTICAL ANALYSIS;

EID: 0031916912     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980417)79:2<153::AID-IJC10>3.0.CO;2-B     Document Type: Article

References (23)

1. BARETTON, G.B., DIEBOLD, J., CHRISTOFORIS, G., VOGT, M., MULLER, C., DOPFER, K., SCHNEIDERBANGER, K., SCHMIDT, M. and LOHRS, U., Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Cancer, 77, 255-264 (1996).
2. CHAN, W.K., MOLE, M.M., LEVISON, D.A., BALL, R.Y., LU, Q.L., PATEL, K. and HANBY, A.M., Nuclear and cytoplasmic bcl-2 expression in endometrial hyperplasia and adenocarcinoma. J. Pathol., 177, 241-246 (1995).
3. CHEN-LEVY, Z., NOURSE, J. and CLEARY, M.L., The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol. cell. Biol., 9, 701-710 (1989).
4. CHHIENG, D.C., ROSS, J.S. and AMBROS, R.A., bcl-2 expression and the development of endometrial carcinoma. Mod. Pathol., 9, 402-406 (1996).
5. DIEBOLD, J., BARETTON, G., FELCHNER, M., MEIER, W., DOPFER, K., SCHMIDT, M. and LOHRS, U., bcl-2 expression, p53 accumulation and apoptosis in ovarian carcinomas. Amer. J. clin. Pathol., 105, 341-349 (1996).
6. FONTANINI, G., VIGNATI, S., BIGINI, D., MUSSI, A., LUCCHI, M., ANGELETTI, C.A., BASOLO, F. and BEVILACQUA, G., Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Brit. J. Cancer, 71, 1003-1007 (1995).
7. COMPEL, A., SABOURIN, J.C., MARTIN, A., YANEVA, H., AUDOUIN, J., DECROIX, Y. and POITOUT, P., Bcl-2 expression in normal endometrium during the menstrual cycle. Amer. J. Pathol., 144, 1195-1202 (1994).
8. HENDERSON, G.S., BROWN, K.S., PERKINS, S.L., ABBOTT, T.M. and CLAYTON, F., bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma. Mod. Pathol., 9, 430-438 (1996).
9. HOCKENBERY, D.M., NUNEZ, G., MILLIMAN, C., SCHREIBER, R.D. and KORSMEYER, S.J., Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348, 334-336 (1990).
10. KOH, E.A., ILLINGWORTH, P.J., DUNCAN, W.C. and CRITCHLEY, H.O., Immunolocalization of bcl-2 protein in human endometrium in the menstrual cycle and simulated early pregnancy. Hum. Reprod., 10, 1557-1562 (1995).
11. KOUVIDOU, CH., KANAVAROS, P., PAPAIOANNOU, D., STATHOPOULOS, B., SOTSIOU, D., DATSERIS, G., TZARDI, M., KITTAS, C. and DELIDES, G., Expression of bcl-2 and p53 proteins in nasopharyngeal carcinoma. Absence of correlation with the presence of EBV-encoded EBER1-2 transcripts and latent membrane protein-1. J. clin. Pathol. mol. Pathol., 48, M17-M22 (1995).
12. KROEMER, G., PETIT, P., ZAMZAMI, N., VAYSSIERE, J-L. and MIGNOTTE, B., The biochemistry of programmed cell death. FASEB J., 9, 1277-1287 (1995).
13. LIPPONEN, P., PIETILAINEN, T., KOSMA, V.M., AALTOMAA, S., ESKELINEN, M. and SYRFANEN, K., Apoptosis-suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J. Pathol., 177, 49-55 (1995).
14. LU, Q.L. and HANBY, A.M., Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J. Cell Sci., 107, 363-371 (1994).
15. NIEMAN, T.H., TRGOVAC, T.L., MCGAUGHY, V.R. and VACCARELLO, L., bcl-2 expression in endometrial hyperplasia and carcinoma. Gynecol. Oncol., 63, 318-322 (1996).
16. OTSUKI, Y., MISAKI, O., SUGIMOTO, O., ITO, Y. TSUJIMOTO, Y. and AKAO, Y., Cyclic bcl-2-gene expression in human uterine endometrium during menstrual cycle. Lancet, 344, 28-29 (1994).
17. PEZZELLA, F. and GATTER, K., What is the value of bcl-2 protein detection for histopathologists? Histopathology, 26, 89-93 (1995).
18. SAEGUSA, M., KAMATA, Y., ISONO, M. and OKAYASU, I., Bcl-2 expression is correlated with a low apoptotoc index and associated with progesterone-receptor immunoreactivity in endometrial carcinoma. J. Pathol., 180, 275-282 (1996).
19. SAKURAGI, N., MATSUO, H., COUKOS, G., FURTH, E.E., BRONNER, M.P., VAN ARSDALE, C.M., KRAJEWSKY, S., REED, J.C. and STRAUSS, J.F., III, Differentiation-dependent expression of the BCL-2 proto-oncogene in the human trophoblast lineage. J. Soc. gynecol. Invest., 1, 164-172 (1994).
20. SIERRA, A., LLOVERAS, B., CASTELLSAGUE, X., MORENO, L., GARCIA-RAMIREZ, M. and FABRA, A., Bcl-2 expression is associated with lymph-node metastasis in human ductal breast carcinoma. Int. J. Cancer, 60, 54-60 (1995).
21. SILVESTRINI, R., BENINI, E., VENERONI, S., DAIDONE, M.G., TOMASIC, G., SQUICCIARINI, P. and SALVADORI, B., p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast-cancer patients. J. clin. Oncol., 14, 1604-1610 (1996).
22. TABIBZADEH, S., ZUPI, E., BABAKNIA, A., LIU, R., MARCONI, D. and ROMANINI, C. Site- and menstrual-cycle-dependent expression of proteins of the tumour-necrosis-factor (TNF)-receptor family, and BCL-2 oncoprotein and phase-specific production of TNF alpha in human endometrium. Hum. Reprod., 10, 277-286 (1995).
23. WILLINGHAM, M.C. and BHALLA, K., Transient mitotic-phase localization of Bcl-2 oncoprotein in human carcinoma cells and its possible role in prevention of apoptosis. J. Histochem. Cytochem., 42, 441-450 (1994).